跳至主要内容
临床试验/NCT01766661
NCT01766661Unknown不适用

Prospective Multicenter Randomized Controlled Trial Comparing Postoperative Complications and Quality of Life in Low Rectal Cancer Surgery Between Coloanal Anastomosis and Lateral Ileostomy Versus Two-Stage Turnbull-Cutait Coloanal Anastomosis

Hospital Universitari de Bellvitge7 个研究点 分布在 2 个国家目标入组 92 人开始时间: 2013年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
92
试验地点
7
主要终点
post-operative morbidity

研究概览

简要总结

The aim of this study is to decrease the morbidity by 30% using the Turnbull-Cutait procedure in comparison to the standard surgery for low rectal cancer. The investigators compare quality of life, faecal incontinence and recurrence of neoplasm in patients who received standard colo-anal anastomosis with protective ileostomy or two-staged Turnbull-Cutait colo-anal anastomosis after Low Anterior Resection for rectal cancer.

详细描述

Anastomotic leak represents the most frequent complication after rectal cancer surgery and a lateral covering ileostomy is usually performed to reduce its incidence. Other important consequences of rectal cancer surgery are alterations in bowel habits and function and a negative impact on quality of life. This prospective, randomized, multicenter and controlled trial compares post-operative complications, quality of life, faecal incontinence and recurrence rate in patients treated for low rectal cancer with colo-anal anastomosis protected by a lateral ileostomy or with a two-staged Turnbull-Cutait colo-anal anastomosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with adenocarcinoma of the lower-middle third of the rectum proctoscopy established by rigid proctoscopy, with histological confirmation and candidates of colo-anal anastomosis;
  • Patients over 18 years and under 75 years, who can tolerate neoadjuvant and surgical treatment;
  • Patients who undergo an ultra-low anterior rectal resection with total mesorectal excision and nerve and sphincter-sparing with curative intention
  • Any extension of the primary tumor (T 1-2-3-4) according to the TNM classification;
  • Patients with or without lymph node metastasis (N - / +) and with or without resectable distant metastases;
  • Patients clinically without fecal incontinence prior to the current illness and with a Wexner incontinence Score less than or equal to 5;
  • Patients ASA I, II or III and adequate hematological, renal and hepatic function;
  • Patients who signed informed consent.

排除标准

  • Altered cognitive state(eg mental retardation or dementia) that prevents collaboration in the study or patients who can neither read nor write
  • Fecal incontinence (Wexner equal to or greater than 6);
  • Previous surgery or proctological, colonic and anorectal functional disease
  • Diagnosis of synchronous colorectal or any other active neoplasm;
  • Patients ASA IV, V;
  • Pregnancy and lactation;
  • Rejection of the patient to sign the consent form.

研究组 & 干预措施

Coloanal anastomosis with ileostomy

Active Comparator

Hand-sewn coloanal anastomosis protected by a loop ileostomy

干预措施: Hand-sewn coloanal anastomosis (Procedure)

Coloanal anastomosis with ileostomy

Active Comparator

Hand-sewn coloanal anastomosis protected by a loop ileostomy

干预措施: Ultralow anterior rectal resection with total mesorectal excision (Procedure)

Two stage Turnbull-Cutait anastomosis

Experimental

Two staged coloanal anastomosis without protective ileostomy (Turnbull-Cutait procedure).

干预措施: Two staged Turnbull-Cutait procedure (Procedure)

Two stage Turnbull-Cutait anastomosis

Experimental

Two staged coloanal anastomosis without protective ileostomy (Turnbull-Cutait procedure).

干预措施: Ultralow anterior rectal resection with total mesorectal excision (Procedure)

结局指标

主要结局

post-operative morbidity

时间窗: within the first 30 days after surgery

次要结局

  • local and/or distant recurrence of neoplasm(3 years)
  • Quality of life(3 years)
  • Fecal incontinence(3 years)

研究者

发起方
Hospital Universitari de Bellvitge
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sebastiano Biondo

PhD, MD

Hospital Universitari de Bellvitge

研究点 (7)

Loading locations...

相似试验